Purchase Order HHSD2002015M87327P
- Not listed
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
- This is a $101,594.39 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has an existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs, and has received prior federal contract...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $79,283.85 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to supply...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $95,931.00 contract is for the provision of laboratory equipment, with no set-aside designation used. Based on Illumina's prior federal contract work, the equipment is likely to include NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along...
- This is a $95,931.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc. for the provision of laboratory equipment. The award does not indicate the use of any set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has a history of providing sequencing systems and related products to support genomic research and diagnostics across various federal...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
- This is a $129,019.17 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of DNA sequencing reagents. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously been awarded federal contracts and subcontracts by agencies such as the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs to...
- This is a purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents. The $137,112.53 firm fixed price contract is for the delivery of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems and related consumables and services to support genomic research and diagnostics for various federal agencies, including the National...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract, valued at $145,412.23, is for the provision of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs. This award appears to be part of a larger indefinite delivery contract with the Department of the Navy Bureau of Medicine and Surgery valued up to $3.3 million, which supports nucleic acid sequencing needs for the Naval Medical Research Center's Biological Defense Research Directorate.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Supplemental Agreement for work within scope | $0 | 9/30/15 | |
| Not listed | Not listed | $145.4k | 8/10/15 |